Related Experiment Video
Updated: Jun 4, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Functional characterization of Trip10 in cancer cell growth and survival
Chia-Chen Hsu1, Yu-Wei Leu, Min-Jen Tseng
1Human Epigenomics Center, Department of Life Science, Institute of Molecular Biology and Institute of Biomedical Science, National Chung Cheng University, Chia-Yi, Taiwan.
Background:
The Cdc42-interacting protein-4, Trip10 (also known as CIP4), is a multi-domain adaptor protein involved in diverse cellular processes, which functions in a tissue-specific and cell lineage-specific manner. We previously found that Trip10 is highly expressed in estrogen receptor-expressing (ER+) breast cancer cells. Estrogen receptor depletion reduced Trip10 expression by progressively increasing DNA methylation. We hypothesized that Trip10 functions as a tumor suppressor and may be involved in the malignancy of ER-negative (ER-) breast cancer. To test this hypothesis and evaluate whether Trip10 is epigenetically regulated by DNA methylation in other cancers, we evaluated DNA methylation of Trip10 in liver cancer, brain tumor, ovarian cancer, and breast cancer.
Methods:
We applied methylation-specific polymerase chain reaction and bisulfite sequencing to determine the DNA methylation of Trip10 in various cancer cell lines and tumor specimens. We also overexpressed Trip10 to observe its effect on colony formation and in vivo tumorigenesis.
Results:
We found that Trip10 is hypermethylated in brain tumor and breast cancer, but hypomethylated in liver cancer. Overexpressed Trip10 was associated with endogenous Cdc42 and huntingtin in IMR-32 brain tumor cells and CP70 ovarian cancer cells. However, overexpression of Trip10 promoted colony formation in IMR-32 cells and tumorigenesis in mice inoculated with IMR-32 cells, whereas overexpressed Trip10 substantially suppressed colony formation in CP70 cells and tumorigenesis in mice inoculated with CP70 cells.
Conclusions:
Trip10 regulates cancer cell growth and death in a cancer type-specific manner. Differential DNA methylation of Trip10 can either promote cell survival or cell death in a cell type-dependent manner.
Insights
Trip10 (also known as CIP4) DNA methylation differs across cancers. Hypermethylation in brain and breast tumors may promote cancer, while hypomethylation in liver cancer suggests a tumor suppressor role for Trip10.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cdc42-interacting protein-4, Trip10 (CIP4), is a multi-domain adaptor protein with tissue-specific functions.
- Trip10 is highly expressed in ER+ breast cancer; its depletion increases DNA methylation.
- Hypothesized Trip10 acts as a tumor suppressor in ER- breast cancer and is epigenetically regulated by DNA methylation in other cancers.
Purpose of the Study:
- To investigate the epigenetic regulation of Trip10 by DNA methylation in liver, brain, ovarian, and breast cancers.
- To evaluate the role of Trip10 as a tumor suppressor or oncogene in different cancer types.
Main Methods:
- Methylation-specific polymerase chain reaction and bisulfite sequencing were used to assess Trip10 DNA methylation.
- Trip10 was overexpressed to study its effects on cell colony formation and in vivo tumorigenesis.
Main Results:
- Trip10 was hypermethylated in brain tumors and breast cancer, but hypomethylated in liver cancer.
- Overexpression of Trip10 promoted colony formation and tumorigenesis in brain tumor (IMR-32) cells.
- Overexpression of Trip10 suppressed colony formation and tumorigenesis in ovarian cancer (CP70) cells.
Conclusions:
- Trip10's role in cancer cell growth and death is cancer-type specific.
- Differential DNA methylation of Trip10 can promote cell survival or cell death depending on the cell type.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

